26041-51-0Relevant articles and documents
Preparation method of hapten acetyl iodothyroxine active coupling reagent
-
Paragraph 0058; 0072-0074, (2021/08/07)
The invention discloses a preparation method of a hapten acetyl iodothyroxine active coupling reagent. The preparation method comprises the following steps: preparing acetic acid active ester; subjecting the prepared acetic acid active ester to reacting with iodothyroxine to synthesize an intermediate compound 1; and subjecting the intermediate compound 1 to reacting with N-hydroxysuccinimide and a condensing agent to synthesize the hapten acetyl iodothyroxine active coupling reagent. The preparation method has the advantages of low price and easy availability of raw materials, few synthesis steps, simplicity in operation, convenience in extraction and purification and high yield, provides a brand new solution for synthesizing the hapten acetyl iodothyroxine active coupling reagent, and overcomes problems in synthesis of artificial antigen key raw materials during preparation of monoclonal antibodies from micromolecule haptens and in synthesis of key raw materials in development of kits for clinical detection of thyroid function items.
Novel derivatives of thyroid hormone and use of thereof
-
Paragraph 0068-0069; 0073, (2020/07/28)
The present invention relates to: a thyroid hormone derivative or a pharmaceutically acceptable salt thereof; a pharmaceutical composition for the prevention or treatment of diseases of the brain and nervous system due to dopamine deficiency, containing the same as an active ingredient; and a method for treating diseases of the brain and nervous system caused by dopamine deficiency. The thyroid hormone derivative according to the present invention can promote the differentiation of neural progenitors into dopamine neurons like thyroid hormones, while lowering the risk of hyperthyroidism by repeated administration, and thus, can be useful for the prevention and treatment of diseases of the brain and nervous system due to dopamine deficiency, including Parkinsonandprime;s disease. A compound or a pharmaceutically acceptable salt thereof is represented by chemical formula 1.COPYRIGHT KIPO 2020
Reagents and methods for the detection and quantification of thyroxine in fluid samples
-
, (2008/06/13)
Immunoassay methods and reagents for the specific quantification of thyroxine in a test sample are disclosed employing antibodies prepared with thyroxine derivatives of the formula: STR1 wherein P is an immunogenic carrier material and X is a linking moiety. The present invention also describes the synthesis of unique labelled reagent of the formula: STR2 wherein Q is a detectable moiety and W is a linking moiety, preferably fluorescein or a fluorescein derivative.